EXTON, Pa., Feb. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it is recognized as one of America's Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group. This survey included interviews with over 220,000 individuals and analysis of more than 1.5 million company reviews collected in 2022 and 2023.
"As a global organization, we know that DEI benefits the entire workforce and supports the overall success of our people, customers and business, which is inherent to our core value of One West Team." said Annette Favorite, Sr. Vice President and Chief Human Resources Officer at West, "We are proud of this award, which celebrates that we offer a culture in which team members across the world — with varying life, educational, cultural and family experiences — all have a voice."
West is dedicated to fostering an environment that celebrates differences and promotes collaboration, ensuring every employee feels supported and has equal opportunities to thrive. Emphasizing diversity is a key aspect of West's recruitment strategy, and today at West, 44% of its senior leaders are women and/or people of color with 53% of them being promoted to senior leadership in 2023. Additionally, West offers Employee Business Resource Groups (EBRGs) in focus areas like multiculturalism, veterans and women's initiatives, with active chapters in regions where West operates.
West's commitment goes beyond its team members, with donations of more than $1 million each year for the last five years to over 40 charities supporting underserved communities from cradle to college, ensuring access to those most at risk and investing in the process with its community partners.
"Diversity is a widely discussed topic – and it remains a crucial factor as people look for an employer or a business partner. Newsweek and market-data research firm Plant-A Insights are proud to introduce 'America's Greatest Workplaces for Diversity 2024,' highlighting companies that are committed to offering diverse and inclusive work environment," said Nancy Cooper, Global Editor-in-Chief, Newsweek.
Read more about West's commitment to diversity in our 2022 ESG Report here.
For the complete Newsweek list of America's Greatest Workplaces for Diversity 2024, please visit https://www.newsweek.com/rankings/americas-greatest-workplaces-diversity-2024.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year.
In 2023, West commemorated a century of groundbreaking innovation that has shaped the landscape of healthcare and impacted the lives of patients around the world. This milestone served as a testament to West's commitment to revolutionize drug delivery and enhance the overall patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
Last Trade: | US$297.24 |
Daily Change: | -3.06 -1.02 |
Daily Volume: | 231,503 |
Market Cap: | US$21.560B |
April 25, 2024 February 15, 2024 December 04, 2023 |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB